Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB386118

MyoD Antibody (MYOD1/3418R), DyLight 405, Novus Biologicals™
SDP

Catalog No. NB386118 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB386118 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB386118 Supplier Novus Biologicals Supplier No. NBP308543V
Add to Cart
Add to Cart

Description

Rabbit Monoclonal Antibody

MyoD Monoclonal antibody specifically detects MyoD in Human samples. It is validated for Immunohistochemistry (Paraffin)

Specifications

Antigen MyoD
Applications Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone MYOD1/3418R
Conjugate DyLight 405
Formulation 50mM Sodium Borate
Gene Alias bHLHc1BHLHC1, Class C basic helix-loop-helix protein 1, MYF3Myf-3, MYODmyoblast determination protein 1, myogenic differentiation 1, Myogenic factor 3myf-3, PUM
Host Species Rabbit
Immunogen Recombinant fragment (around aa1-100) of human MyoD protein (exact sequence is proprietary) (Uniprot: P15172 )
Purification Method Protein A purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Cancer, Cell Cycle and Replication, Growth and Development
Primary or Secondary Primary
Gene ID (Entrez) 4654
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.